Dykhuizen Lab
@dykhuizenlab.bsky.social
📤 464
📥 222
📝 2
We work on understanding and targeting chromatin binding domains. www.dykhuizenlab.com
reposted by
Dykhuizen Lab
Sarafan ChEM-H
8 months ago
ENPP1 drug developed by Institute Scholar
@lingyinli.bsky.social
gains FDA approval for Phase I cancer clinical trials:
arcinstitute.org/news/stf-162...
loading . . .
Proof-of-concept innate immune checkpoint inhibitor shows promise against solid tumors in rodents | Arc Institute
Biochemist Lingyin Li has been pioneering a new direction for immunotherapy, searching for drugs that would turn these “cold” environments “hot”. Instead of stimulating T cells in the adaptive immune…
https://arcinstitute.org/news/stf-1623-innate-immune-checkpoint-inhibitor
0
8
5
reposted by
Dykhuizen Lab
H. Courtney Hodges
11 months ago
How do chromatin remodelers use
#IDRs
to find TF binding partners? In our new Molecular Cell paper, we show that β-catenin is an adaptor that links SWI/SNF (cBAF) subunit ARID1A with binding partners via IDR-domain interactions.
www.cell.com/molecular-ce...
11
89
38
reposted by
Dykhuizen Lab
Jordan Meier
about 1 year ago
Great news: NIH postbac program is recruiting again! If your grad school plans were affected by program cutbacks or admissions freezes this year I highly encourage you to apply, this could be a perfect opportunity. Please repost.
www.training.nih.gov/research-tra...
loading . . .
https://www.training.nih.gov/research-training/pb/pb/
6
208
197
Former Lab member
@sijiewang.bsky.social
kicking ass in his postdoc!
@krusemarklab.bsky.social
add a skeleton here at some point
over 1 year ago
0
3
1
you reached the end!!
feeds!
log in
